Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription


6 AJR Am J Roentgenol
1 Am J Pathol
1 BMC Gastroenterol
1 Br J Surg
1 Clin Res Hepatol Gastroenterol
1 Dig Dis
1 Eur Radiol
4 Hepatology
1 J Clin Oncol
1 J Gastroenterol
13 J Hepatol
1 PLoS Genet
8 PLoS One
2 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. CHERNYAK V, van der Pol CB, Vernuccio F, Yoshimitsu K, et al
    The Global Reading Room: Imaging Detection of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26909.

  2. RANATHUNGA D, Osman H, Islam N, McInnes MD, et al
    Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk for Hepatocellular Carcinoma: A Retrospective Study.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26376.
    PubMed         Abstract available

    Editorial Comment: Liver Fat Quantification by Ultrasound-Potential to Change Diagnosis and Management of Pediatric NAFLD.
    AJR Am J Roentgenol. 2021 Feb 10. doi: 10.2214/AJR.21.25594.

    Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease".
    AJR Am J Roentgenol. 2021;217:1012.

  5. GEMERY JM, Munger DP, Hoffer EK
    Factors in Spleen Size After TIPS Placement.
    AJR Am J Roentgenol. 2021;217:1013.

  6. LIU J, Ma J, Yang C, Ye T, et al
    Reply to "Factors in Spleen Size After TIPS Placement".
    AJR Am J Roentgenol. 2021;217:1013.

    Am J Pathol

  7. GOTTLIEB A, Dev S, DeVine L, Gabrielson KL, et al
    Am J Pathol. 2021 Oct 7. pii: S0002-9440(21)00435.
    PubMed         Abstract available

    BMC Gastroenterol

  8. KOLESOVA O, Vanaga I, Laivacuma S, Derovs A, et al
    Intriguing findings of liver fibrosis following COVID-19.
    BMC Gastroenterol. 2021;21:370.
    PubMed         Abstract available

    Br J Surg

  9. ZHONG JH, Xing BC, Zhang WG, Chan AW, et al
    Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a retrospective multicentre study.
    Br J Surg. 2021 Oct 13. pii: 6395264. doi: 10.1093.
    PubMed         Abstract available

    Clin Res Hepatol Gastroenterol

  10. MORANDEAU E, Rayer C, Jezequel C, Guyader D, et al
    Hepatic encephalopathy post liver transplantation.
    Clin Res Hepatol Gastroenterol. 2020 Mar 10. pii: S2210-7401(20)30039.

    Dig Dis

  11. REITER FP, Ben Khaled N, Ye L, Zhang C, et al
    Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State of the Art Review.
    Dig Dis. 2021 Oct 13. pii: 000520095. doi: 10.1159/000520095.

    Eur Radiol

  12. YANG J, Huang JY, Chen X, Ling WW, et al
    Correction to: Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Oct 14. pii: 10.1007/s00330-021-08256.


  13. GRAHAM JJ, Mukherjee S, Yuksel M, Sanabria Mateos R, et al
    Aberrant hepatic trafficking of gut-derived T-cells is not specific to primary sclerosing cholangitis.
    Hepatology. 2021 Oct 11. doi: 10.1002/hep.32193.
    PubMed         Abstract available

  14. Correction of HEPATOLOGY 2020;71:259-274.
    Hepatology. 2021 Oct 12. doi: 10.1002/hep.32036.

  15. XU H, Tian Y, Tang D, Zou S, et al
    An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD.
    Hepatology. 2021;73:1327-1345.
    PubMed         Abstract available

  16. DHAR D, Loomba R
    Emerging Metabolic and Transcriptomic Signature of PNPLA3-Associated NASH.
    Hepatology. 2021;73:1248-1250.

    J Clin Oncol

  17. LI QJ, He MK, Chen HW, Fang WQ, et al
    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.
    J Clin Oncol. 2021 Oct 14:JCO2100608. doi: 10.1200/JCO.21.00608.
    PubMed         Abstract available

    J Gastroenterol

  18. SCHWARZER R, Reiberger T, Mandorfer M, Kivaranovic D, et al
    The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
    J Gastroenterol. 2019 Dec 12. pii: 10.1007/s00535-019-01656.
    PubMed         Abstract available

    J Hepatol

  19. FERRARESE A, Plebani M, Frigo AC, Burra P, et al
    Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease.
    J Hepatol. 2021;75:232-234.

  20. QING J, Ren Y, Zhang Y, Yan M, et al
    Dopamine receptor D2 antagonization normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis.
    J Hepatol. 2021 Oct 11. pii: S0168-8278(21)02097.
    PubMed         Abstract available

  21. SCHEINER B, Pomej K, Kirstein MM, Hucke F, et al
    Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
    J Hepatol. 2021 Oct 11. pii: S0168-8278(21)02100.
    PubMed         Abstract available

  22. SEN P, Qadri S, Luukkonen PK, Ragnarsdottir O, et al
    Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease.
    J Hepatol. 2021 Oct 7. pii: S0168-8278(21)02104.
    PubMed         Abstract available

  23. PINYOL R, Torrecilla S, Wang H, Montironi C, et al
    Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878].
    J Hepatol. 2021 Oct 6. pii: S0168-8278(21)02044.

  24. WANG X, Luo X, Yang L
    Achieving an effective pressure reduction after TIPS: The need for a new target.
    J Hepatol. 2021;75:246-248.

  25. WEN X, Tong J, Yao M, Hu J, et al
    Prognostic value of HDL-related biomarkers in patients with HBV-related ACLF.
    J Hepatol. 2021;75:243-245.

  26. XU L, Wettschureck N, Bai Y, Yuan Z, et al
    Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice.
    J Hepatol. 2021;75:238-241.

  27. SIMBRUNNER B, Costa D, Reiberger T
    Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease".
    J Hepatol. 2021;75:234-236.

  28. STAUBER RE, Scharnagl H, Marsche G
    Reply to: "Prognostic value of HDL-related biomarkers in patients with HBV-related ACLF".
    J Hepatol. 2021;75:245-246.

  29. BOSCH J
    Reply to: "Achieving an effective pressure reduction after TIPS: The need for a new target".
    J Hepatol. 2021;75:248-249.

  30. LIU Y, Xu N, Ji H
    Reply to: "Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice".
    J Hepatol. 2021;75:241-243.

    FXR agonists for NASH: How are they different and what difference do they make?
    J Hepatol. 2021;75:12-15.

    PLoS Genet

  32. KESHVARI S, Caruso M, Teakle N, Batoon L, et al
    CSF1R-dependent macrophages control postnatal somatic growth and organ maturation.
    PLoS Genet. 2021;17:e1009605.
    PubMed         Abstract available

    PLoS One

  33. LOOSEN SH, Castoldi M, Jordens MS, Roy S, et al
    Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.
    PLoS One. 2021;16:e0247917.
    PubMed         Abstract available

  34. HUANG CY, Chang YJ, Wei PL, Hung CS, et al
    Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.
    PLoS One. 2021;16:e0248521.
    PubMed         Abstract available

  35. MISHIMA K, Itano O, Matsuda S, Suzuki S, et al
    Development of human hepatocellular carcinoma in X-linked severe combined immunodeficient pigs: An orthotopic xenograft model.
    PLoS One. 2021;16:e0248352.
    PubMed         Abstract available

  36. LIN SY, Chen CM, Huang BS, Lai YC, et al
    A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness.
    PLoS One. 2021;16:e0249003.
    PubMed         Abstract available

  37. KEHL T, Biermann D, Briem-Richter A, Schoen G, et al
    Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease.
    PLoS One. 2021;16:e0248776.
    PubMed         Abstract available

  38. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    PubMed         Abstract available

  39. SAEKI C, Saito M, Kanai T, Nakano M, et al
    Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.
    PLoS One. 2021;16:e0249728.
    PubMed         Abstract available

  40. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    PubMed         Abstract available


  41. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    PubMed         Abstract available

  42. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.